is retatrutide a glp1 Retatrutide, GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Reta GLP-3R (Retatrutide) 10mg |
Pay in 4 interest-free payments of $7.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7















:format(jpg)/d2lnr5mha7bycj.cloudfront.net/product-image/file/large_be89500a-e57e-45f9-b5ec-2b7154aadf27.png)








